Digital innovation in clinical trials

Strategic implications for drug and device development

Scott Gottlieb
23rd commissioner of the FDA
Shwen Gwee
VP of Global Digital Strategy
Bristol Myers Squibb
Joel Haspel
SVP Strategy, Science Group
Clarivate